Aberrant esophageal HLA-DR expression in a high percentage of patients with Crohn's disease

American Journal of Surgical Pathology

Volumn 23, Issue 8, 1999, Pages 970-976

  Oberhuber, Georg ^a   Püspök, Andreas ^a   Peck Radosavlevic, Markus ^a   Kutilek, Mathilde ^a   Lamprecht, Andrea ^a   Chott, Andreas ^a   Vogelsang, Harald ^a   Stolte, Manfred ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

Crohn's disease; Esophagus; Histology; HLA DR expression

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD57 ANTIGEN; CD68 ANTIGEN; GRANZYME B; HLA DR ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ESOPHAGITIS; ESOPHAGUS MUCOSA; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; T LYMPHOCYTE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BIOPSY; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL DISEASES; ESOPHAGUS; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; UP-REGULATION;

EID: 0345210946     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199908000-00016     Document Type: Article

References (37)

1. Anderson P, Nagler Anderson C, C OB, Levine H, Watkins S, Slayter HS, Blue ML, Schlossman SF. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990; 144:574-82.
2. Bennett M, O'Connell J, O'Sullivan G, Roche D, Brady C, Kelly J, Collins JK, Shanahan F. FAS ligand expression by normal esophageal epithelium: another site of immune privilege. Gastroenterology 1998;114:A929.
3. Beschorner WE, Farmer ER, Saral R, Stirling WL, Santos GW. Epithelial class II antigen expression in cutaneous graft-versus-host disease. Transplantation 1987;44:237-43.
4. Best WR, Becktel JM, Singleton JW, Kern F, Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
5. Breese E, Braegger CP, Corrigan CJ, Walker Smith JA, MacDonald TT. Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-3.
6. Cameron DJS. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol 1991;6:355-8.
7. Choy MY, Walker Smith JA, Williams CB, MacDonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 1990;31:1365-70.
8. D. Haens G, Geboes K, Peeters M, Baert F, Pennickx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114: 262-7.
9. D'Haens G, Rutgeerts P, Geboes K, Vantrappen G. The natural history of esophageal Crohn's disease: three patterns of evolution. Gastrointest Endosc 1994;40:296-300.
10. Dancygier H, Frick B. Crohn's disease of the upper gastrointestinal tract. Endoscopy 1992;24:555-8.
11. Fais S, Capobianchi MR, Marcheggiano A, Iannoni C, Pallone F. MHC class II antigens on the epithelial cells of the human gastrointestinal tract. Gastroenterology 1992;102:377-8.
12. Geboes K, De Wolf Peeters C, Rutgeerts P, Janssens J, Vantrappen G, Desmet V. Lymphocytes and Langerhans cells in the human oesophageal epithelium. Virchows Arch A Pathol Anat Histopathol 1983;401:45-55.
13. Geboes K, Janssens J, Rutgeerts P, Vantrappen G. Crohn's disease of the esophagus. J Clin Gastroenterol 1986;8:31-7.
14. Geboes K, Rutgeerts P, Stessens L, Vantrappen G, Desmet V. Expression of MHC Class II antigens by oesophageal epithelium in herpes simplex oesophagitis. Histopathology 1985;9:711-8.
15. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992;10:13-49.
16. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991;12:415-9.
17. Guardiola J, Maffei A. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit Rev Immunol 1993;13:247-68.
18. Hanson RD, Ley TJ. Transcriptional activation of the human cytotoxic serine protease gene CSP-B in T lymphocytes. Mol Cell Biol 1990;10:5655-62.
19. Koller U, Stockinger H, Majdic O, Bettelheim P, Knapp W. A rapid and simple immunoperoxidase staining procedure for blood and bone marrow samples. J Immunol Methods 1986;86:75-81.
20. Kummer JA, Kamp AM, van Katwijk M, Brakenhoff JP, Radosevic K, van Leeuwen AM, Borst J, Verweij CL, et al. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods 1993;163:77-83.
21. Lampert IA, Suitters AJ, Chisholm PM. Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease. Nature 1981;293:149-150.
22. Lennard Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
23. Lowes JR, Radwan P, Priddle JD, Jewell DP. Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease. Gut 1992;33:315-9.
24. Meining A, Bayerdorffer E, Bastlein E, Raudis N, Thiede C, Cyrus B, Kramer W, Klann H, et al. Focal Inflammatory Infiltrations in Gastric Biopsy Specimens Are Suggestive of Crohns Disease. Scand J Gastroenterol 1997;32:813-8.
25. Oberhuber G, Bodingbauer M, Mosberger I, Stolte M, Vogelsang H. High proportion of granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis. Am J Surg Pathol 1998;22:450-8.
26. Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn' s disease. Virchows Archiv An Intl J of Pathol 1998;432:49-52.
27. Oberhuber G, Puspok A, Oesterreicher C, Novacek G, Zauner C, Burghuber M, Vogelsang H, Potzi R, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997;112:698-706.
28. Oberhuber G, Vogelsang H, Stolte M, Muthenthaler S, Kummer AJ, Radaszkiewicz T. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis. Am J Pathol 1996;148:1351-7.
29. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997;150:823-32.
30. Saitoh A, Osada A, Kitajima Y, Furue M, Tamaki K. Interferon-gamma-induced HLA-DR, but not ICAM-1, expression of human keratinocytes is down-regulated by calmodulin antagonist. J Dermatol 1994;21:716-9.
31. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J of Gastroenterology 1997;92: S5-S11.
32. Schmitz Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn's disease patients. Pathol Res Pract 1985;179:377-87.
33. Selby WS, Janossy G, Mason DY, Jewell DP. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin-Exp Immunol 1983;53:614-8.
34. Singaram C, Sengupta A, Stevens C, Spechler SJ, Goyal RK. Localization of calcitonin gene-related peptide in human esophageal Langerhans cells. Gastroenterology 1991;100:560-3.
35. Sviland L, Pearson AD, Green MA, Eastham EJ, Malcolm AJ, Proctor SJ, Hamilton PJ. Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group. Bone Marrow Transplant 1989;4:233-8.
36. Voiglio E, Salle B, Lemaitre D, Cloix P, Bancel B, Cozon G. [Activation of T-lymphocytes in Crohn disease and in ulcerative hemorrhagic rectocolitis. Therapeutic implications]. Pathol Biol Paris 1996;44:287-92.
37. Wright CL, Riddell RH. Histology of the stomach and duodenum in Crohn's disease. Am J Surg Pathology 1998;22:383-90.